Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 84

Sort by

Sort Order Select

Journal Articles

Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial

Blood (2019) 134 (Supplement_1): 3000.

https://doi.org/10.1182/blood-2019-126744

Published: 2019

Journal Articles

Efficacy and Safety of BAY 94-9027 (Damoctocog Alfa Pegol) Prophylaxis in Patients with Severe Hemophilia a and Comorbidities: A Post Hoc Analysis of PROTECT VIII Data

Wolfgang A. Miesbach, Giovanni Di Minno, Elena Santagostino, Dr. Klamroth, Inga Bayh, Amaryllis Soto, Cedric Hermans

Blood (2019) 134 (Supplement_1): 1117.

https://doi.org/10.1182/blood-2019-128486

Published: 2019

Journal Articles

Immune Thrombocytopenia in US Clinical Practice: Incidence and Healthcare Utilization/Expenditures in the First 12 Months Following Diagnosis

Derek Weycker, PhD, Aaron Grossman, MD MPH, Ahuva Hanau, BS, Hongsheng Wu, PhD, Mark Hatfield, PhD, Anjali Sharma, MD, Mark E. Bensink, PhD MSc, MD, David Chandler, PhD, Michael D. Tarantino, MD

Blood (2018) 132 (Supplement 1): 2239.

https://doi.org/10.1182/blood-2018-99-113429

Published: 2018

Journal Articles

The Frequency of Primary Immune Thrombocytopenia (idiopathic thrombocytopenic purpura) in Patients with Isolated Thrombocytopenia

Anait L. Melikyan, MD PhD, Elena K Egorova, MD, Elena I Pustovaya, MD, Tamara I Kolosheynova, MD, Irina N Subortseva, MD, Elena A Gilyazitdinova, Valeriy G. Savchenko, MD PhD

Blood (2018) 132 (Supplement 1): 4982.

https://doi.org/10.1182/blood-2018-99-111654

Published: 2018

Journal Articles

Chronic HCV Infection and Autologous Stem Cell Transplantation for Multiple Myeloma

Blood (2018) 132 (Supplement 1): 5632.

https://doi.org/10.1182/blood-2018-99-115266

Published: 2018

Journal Articles

Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individuals

Felicia A. Tucci, Simo Kitanovski, Patricia Johansson, Ludger Klein-Hitpass, Alisan Kahraman, Jan Dürig, Daniel Hoffmann, Ralf Küppers

Blood (2018) 131 (5): 546–557.

https://doi.org/10.1182/blood-2017-09-805762

Published: 2018

Includes: Supplemental data

Journal Articles

Is HCV Infection a Risk Factor for Cardiac Complications in TM?

Antonella Meloni, PhD, Laura Pistoia, MD, Saveria Campisi, Francesco Massei, Sabrina Armari, Maurizio Caniglia, Roberta Renni, Giovanni Palazzi, Aurelio Maggio, MD, Vincenzo Positano, Emanuele Grassedonio, Alessia Pepe, MD

Blood (2017) 130 (Supplement 1): 4766.

https://doi.org/10.1182/blood.V130.Suppl_1.4766.4766

Published: 2017

Journal Articles

Efficacy and Safety of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Virus Infection and Inherited Blood Disorders: Final Data from the C-Edge Ibld Study

Blood (2016) 128 (22): 1303.

https://doi.org/10.1182/blood.V128.22.1303.1303

Published: 2016

Journal Articles

Platelet Count Increase Seen with Ledipasvir-Sofosbuvir Combination Treatment of Chronic Hepatitis C in Patients with Thrombocytopenia

Hind Rafei, MD, Joao L. Ascensao, MD PhD, Anita Aggarwal, DO, PhD

Blood (2016) 128 (22): 5967.

https://doi.org/10.1182/blood.V128.22.5967.5967

Published: 2016

Journal Articles

Splenic Marginal Zone Lymphoma in an East Mediterranean/Middle Eastern Population Cohort: Possible Association with Hepatitis B Instead of Hepatitis C Virus As an Etiologic and Prognostic Factor (ThREG-NHL01 Study)

Tuncay Aslan, Evren Ozdemir, MD, Aysegul Uner, Elif Gungor, Nevin Alayvaz Aslan, Esra Yildizhan, MD, Abdullah Agit, Serdal Korkmaz, MD, Gulsum Akgun Cagliyan, Ibrahim Barista, MD, Esra Ozhamam, Gulsum Emel Pamuk, MD, Mehmet Turgut, MD PhD, Bulent Eser, Gulsum Ozet, MD, Rahsan Yıldırım, Yahya Buyukasik, MD

Blood (2016) 128 (22): 5332.

https://doi.org/10.1182/blood.V128.22.5332.5332

Published: 2016

Journal Articles

High Sensitivity Hepcidin-25 Bioactive Elisas: Manual and Fully Automated System for the Quantification of Hepcidin-25 in Human Serum and Plasma

B. Uelker, Ian Cushman, PhD, T. Dudek, Dr. Matthias Herkert, PhD, Dr. Cyril E. Geacintov, PhD

Blood (2016) 128 (22): 4820.

https://doi.org/10.1182/blood.V128.22.4820.4820

Published: 2016

Journal Articles

The Effect of Hepatitis C - Direct-Acting Antiviral Treatment on the Hematogical Profile of Thalassemic Patients

Sotirios Bristogiannis, MD, Antonios Kattamis, MD, Dimitra Kyriakopoulou, MD, Maria Moraki, MD, Dimitrios Kountouras, MD PhD, Nikolaos Alexiou, MD

Blood (2016) 128 (22): 2471.

https://doi.org/10.1182/blood.V128.22.2471.2471

Published: 2016

Journal Articles

Safety and Efficacy of Direct-Acting Antiviral Drugs in Patients with Haemoglobinophaties and Chronic Hepatitis C Infection

Antonio Piga, MD, Paolo Rigano, MD, Raffaella Origa, MD, M. Domenica Cappellini, MD, Valeria Pinto, MD, Immacolata Tartaglione, MD, Aldo Filosa, MD, Domenico D'Ascola, MD, Vito Di Marco, Gian Luca Forni, MD

Blood (2016) 128 (22): 3627.

https://doi.org/10.1182/blood.V128.22.3627.3627

Published: 2016

Journal Articles

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection

Blood (2016) 128 (21): 2527–2532.

https://doi.org/10.1182/blood-2016-05-714667

Published: 2016

Includes: Supplemental data

Journal Articles

How I treat hepatitis C virus infection in patients with hematologic malignancies

Harrys A. Torres, George B. McDonald

Blood (2016) 128 (11): 1449–1457.

https://doi.org/10.1182/blood-2016-05-718643

Published: 2016

Journal Articles

The Analysis of Mutual Relationship Between Hemostasis and Inflammatory Processes in Patients with Chronic Liver Diseases

Nora E. El-Bassiouni, MD PhD, Rania M. Benyamin, M.Sc., Samia H. Risk, MD PhD, Manal Y. Zahran, MD PhD, Ola M. Mahmoud, MD PhD, Raafat A. Ibrahim, MD PhD, Azza E. El Bassiouny, MD PhD

Blood (2015) 126 (23): 1015.

https://doi.org/10.1182/blood.V126.23.1015.1015

Published: 2015

Journal Articles

Bone Marrow Findings in Veterans (V) with Hepatitis C Infection (HCV) at a VA Medical Center

Shanthi Srinivas, MD, Katherine Kim, MD, Melanie Gonzalez, Fengming Zhong, MDPhD, Barbara Crump, APN, Chang Victor, MD

Blood (2015) 126 (23): 4632.

https://doi.org/10.1182/blood.V126.23.4632.4632

Published: 2015

Journal Articles

Randomized, Open Label, Phase IIa Controlled Trials Evaluating the Safety of the Association of Deferasirox with Standard Antiviral Therapy (Peg-interferon and Ribavirin) in Patients with Chronic Hepatitis C

Francesca Pileri, MD, Alberto Vegetti, MD, Luca De Pietri, MD, Gianluca Abbati, MD, Paolo Ventura, MD, Maria Rita Gamberini, MD, Vincenzo Caruso, Francesca Ferrara, Antonello Pietrangelo, MD, PhD

Blood (2014) 124 (21): 4075.

https://doi.org/10.1182/blood.V124.21.4075.4075

Published: 2014

Journal Articles

Therapeutic Infusion of Partially HLA-Matched Third-Party Virus-Specific T Cells in HSCT Patients with Refractory Viral Infection

Leighton Edward Clancy, PhD, Emily Blyth, Barbara Withers, Jane Burgess, Renee Simms, Chun Kei Kris Ma, B.Sc (MD MB BS FRACP FRCPA, Kenneth P. Micklethwaite, MD PhD, David Gottlieb, MB MDFRCPA FRACP

Blood (2014) 124 (21): 3835.

https://doi.org/10.1182/blood.V124.21.3835.3835

Published: 2014

Journal Articles

Second Generation Direct-Acting Antiviral Agents Eradicate Hepatitis C Virus (HCV) but Exacerbate Thrombocytopenia in a Patient with HCV-Associated Immune Thrombocytopenic Purpura (ITP): Case Report

Le Min Lee, MD, Max E Johansen, BS, Wenche Jy, PhD, Lawrence L Horstman, BS, Yeon-Soong Ahn, MD

Blood (2014) 124 (21): 5022.

https://doi.org/10.1182/blood.V124.21.5022.5022

Published: 2014

NARROW

Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial

Efficacy and Safety of BAY 94-9027 (Damoctocog Alfa Pegol) Prophylaxis in Patients with Severe Hemophilia a and Comorbidities: A Post Hoc Analysis of PROTECT VIII Data

Immune Thrombocytopenia in US Clinical Practice: Incidence and Healthcare Utilization/Expenditures in the First 12 Months Following Diagnosis

The Frequency of Primary Immune Thrombocytopenia (idiopathic thrombocytopenic purpura) in Patients with Isolated Thrombocytopenia

Chronic HCV Infection and Autologous Stem Cell Transplantation for Multiple Myeloma

Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individuals

Is HCV Infection a Risk Factor for Cardiac Complications in TM?

Efficacy and Safety of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Virus Infection and Inherited Blood Disorders: Final Data from the C-Edge Ibld Study

Platelet Count Increase Seen with Ledipasvir-Sofosbuvir Combination Treatment of Chronic Hepatitis C in Patients with Thrombocytopenia

Splenic Marginal Zone Lymphoma in an East Mediterranean/Middle Eastern Population Cohort: Possible Association with Hepatitis B Instead of Hepatitis C Virus As an Etiologic and Prognostic Factor (ThREG-NHL01 Study)

High Sensitivity Hepcidin-25 Bioactive Elisas: Manual and Fully Automated System for the Quantification of Hepcidin-25 in Human Serum and Plasma

The Effect of Hepatitis C - Direct-Acting Antiviral Treatment on the Hematogical Profile of Thalassemic Patients

Safety and Efficacy of Direct-Acting Antiviral Drugs in Patients with Haemoglobinophaties and Chronic Hepatitis C Infection

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection

How I treat hepatitis C virus infection in patients with hematologic malignancies

The Analysis of Mutual Relationship Between Hemostasis and Inflammatory Processes in Patients with Chronic Liver Diseases

Bone Marrow Findings in Veterans (V) with Hepatitis C Infection (HCV) at a VA Medical Center

Randomized, Open Label, Phase IIa Controlled Trials Evaluating the Safety of the Association of Deferasirox with Standard Antiviral Therapy (Peg-interferon and Ribavirin) in Patients with Chronic Hepatitis C

Therapeutic Infusion of Partially HLA-Matched Third-Party Virus-Specific T Cells in HSCT Patients with Refractory Viral Infection

Second Generation Direct-Acting Antiviral Agents Eradicate Hepatitis C Virus (HCV) but Exacerbate Thrombocytopenia in a Patient with HCV-Associated Immune Thrombocytopenic Purpura (ITP): Case Report

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only